Sangamo Therapeutics
SGMO
SGMO
179 hedge funds and large institutions have $198M invested in Sangamo Therapeutics in 2023 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 75 increasing their positions, 40 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 182 → 179 (-3)
37% less capital invested
Capital invested by funds: $315M → $198M (-$118M)
Holders
179
Holding in Top 10
–
Calls
$248K
Puts
$110K
Top Buyers
| 1 | +$6.07M | |
| 2 | +$3.22M | |
| 3 | +$1.96M | |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
+$1.92M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$1.75M |
Top Sellers
| 1 | -$3.43M | |
| 2 | -$1.91M | |
| 3 | -$1.46M | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$1.1M |
| 5 |
Axa
Paris,
France
|
-$916K |